Watch These Moderna Price Levels as Stock Plummets After Slashing 2025 Revenue Outlook
1. Moderna shares fell nearly 17% after cutting 2025 revenue forecast by $1 billion. 2. Stock breakdown indicates potential for further declines in price performance. 3. Key support levels are around $30 and $13; crucial resistance at $57 and $68. 4. Moderna plans to cut $1.5 billion in expenses amidst rising development costs. 5. Stock has lost about two-thirds of its value in the past year.